Yahoo
Shenzhen - Delayed Quote CNY

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)

22.02 -1.61 (-6.81%)
At close: October 30 at 3:04:57 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,101,987.84
2,522,737.62
2,467,418.39
2,610,550.12
2,676,151.62
Cost of Revenue
947,662.53
1,107,007.58
1,084,821.83
1,080,875.27
940,486.38
Gross Profit
1,154,325.30
1,415,730.04
1,382,596.57
1,529,674.85
1,735,665.23
Operating Expense
961,584.48
1,095,120.19
1,108,056.09
1,177,794.51
1,340,915.40
Operating Income
192,740.82
320,609.86
274,540.47
351,880.35
394,749.83
Net Non Operating Interest Income Expense
1,458.36
3,645.48
-7,423.51
-16,788.03
-46,576.80
Pretax Income
211,893.82
296,585.83
-335,881.69
283,656.88
368,302.08
Tax Provision
11,492.48
29,881.26
38,081.80
33,755.94
52,953.67
Net Income Common Stockholders
201,757.88
275,754.92
-299,157.12
263,273.18
322,050.28
Basic EPS
0.24
0.33
-0.36
0.32
0.40
Diluted EPS
0.24
0.33
-0.36
0.32
0.40
Basic Average Shares
839,822.29
835,620.97
830,991.99
822,728.69
805,125.71
Diluted Average Shares
839,822.29
835,620.97
830,991.99
822,728.69
805,125.71
Total Operating Income as Reported
208,801.55
298,299.49
-279,951.94
298,730.83
374,262.54
Rent Expense Supplemental
1,306.47
1,645.96
911.73
885.66
3,651.65
Total Expenses
1,909,247.02
2,202,127.76
2,192,877.92
2,258,669.77
2,281,401.78
Net Income from Continuing & Discontinued Operation
201,757.88
275,754.92
-299,157.12
263,273.18
322,050.28
Normalized Income
202,927.97
317,193.29
130,360.21
316,039.50
330,281.75
Interest Income
4,910.47
8,861.66
18,767.67
30,610.02
27,626.78
Interest Expense
2,805.83
4,996.93
25,345.33
46,911.92
73,357.21
Net Interest Income
1,458.36
3,645.48
-7,423.51
-16,788.03
-46,576.80
EBIT
214,699.65
301,582.76
-310,536.36
330,568.80
441,659.29
EBITDA
214,699.65
426,414.07
-185,784.92
451,721.95
541,228.69
Reconciled Cost of Revenue
947,662.53
1,107,007.58
1,084,821.83
1,080,875.27
940,486.38
Reconciled Depreciation
121,873.90
124,831.31
124,751.44
121,153.16
99,569.41
Net Income from Continuing Operation Net Minority Interest
201,757.88
275,754.92
-299,157.12
263,273.18
322,050.28
Total Unusual Items Excluding Goodwill
-1,237.19
-46,081.08
-572,689.77
-59,893.85
-9,613.70
Total Unusual Items
-1,237.19
-46,081.08
-572,689.77
-59,893.85
-9,613.70
Normalized EBITDA
215,936.85
472,495.15
386,904.84
511,615.80
550,842.39
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-67.10
-4,642.71
-143,172.44
-7,127.53
-1,382.24
12/31/2022 - 12/11/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: